Results 131 to 140 of about 659,528 (297)

Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland [PDF]

open access: yes, 2018
While acute respiratory tract infections can trigger cardiovascular events, the differential effect of specific organisms is unknown. This is important to guide vaccine policy.Using national infection surveillance data linked to the Scottish Morbidity ...
Andrew C. Hayward   +9 more
core   +3 more sources

Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa

open access: yesPLoS ONE, 2017
Introduction Streptococcus pneumoniae is a leading cause of severe bacterial infections globally. A full understanding of the impact of pneumococcal conjugate vaccine (PCV) on pneumococcal disease burden, following its introduction in 2009 in South ...
C. von Mollendorf   +11 more
semanticscholar   +1 more source

A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus [PDF]

open access: bronze, 1979
John H. Klippel   +5 more
openalex   +1 more source

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland

open access: yesJournal of the Pediatric Infectious Diseases Society, 2016
After administering the 10-valent pneumococcal polysaccharide nontypeable Haemophilus influenzae protein D–conjugated vaccine (PHiD-CV) to children aged 2–18 months, we observed a reduction in vaccine-type nasopharyngeal carriage, resulting in a ...
T. Vesikari   +12 more
semanticscholar   +1 more source

PROGNOSTICATION OF VACCINATION EFFICACY

open access: yesПедиатрическая фармакология, 2010
The article focuses on the study of protective immunity in vaccination with pneumococcal conjugated 7-valent vaccine (PCV7) against related vaccine serotypes.
N.F. Snegova   +3 more
doaj   +2 more sources

A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults

open access: yesBMC Pulmonary Medicine, 2016
BackgroundInvasive pneumococcal disease (IPD) and pneumococcal pneumonia are common and carry a significant morbidity and mortality. Current strategies to prevent pneumococcal disease are under review in the United Kingdom (UK). We conducted a systematic
J. Chalmers   +4 more
semanticscholar   +1 more source

PNEUMOCOCCAL INFECTION IN RUSSIA: EPIDEMIOLOGICAL SITUATION

open access: yesПедиатрическая фармакология, 2010
The article features an analysis of available literature on the incidence, etiological characteristics, clinical forms of pneumococcal infections in the Russian Federation with a break-down by age group highlighting risk factors. It provides clinical and
I.S. Koroleva   +4 more
doaj   +2 more sources

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children

open access: yesJournal of Global Infectious Diseases, 2019
Context: Although the incidence of invasive pneumococcal infections in children has decreased since the introduction of pneumococcal conjugate vaccines (PCVs), the appearance of serotype replacements has continued to increase.
Hiroaki Takeda   +8 more
doaj   +1 more source

1067 CLINICAL STUDIES IN INFANTS OF TWO PNEUMOCOCCAL VACCINES [PDF]

open access: bronze, 1981
Sarah H. Sell   +4 more
openalex   +1 more source

SAFETY AND IMMUNOGENICITY OF TWO LOTS OF PNEUMOCOCCAL CONJUGATE VACCINE IN INFANTS. ▴ 1116 [PDF]

open access: bronze, 1996
Kenneth M. Zangwill   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy